Syndax Pharmaceuticals, Inc. (SNDX)

NASDAQ: SNDX · Real-Time Price · USD

20.37

-0.03 (-0.15%)

At close: Aug 10, 2026, 4:00 PM EDT

20.30

-0.07 (-0.34%)

After-hours: Aug 10, 2026, 7:34 PM EDT

Syndax Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	336.48	134.93	154.08	295.39	74.36	221.97
Short-Term Investments	217.79	278.76	428.83	282.19	410.04	224.87
Cash & Short-Term Investments	554.27	413.69	582.91	577.58	484.4	446.83
Cash Growth	18.25%	-29.03%	0.92%	19.24%	8.41%	52.47%
Accounts Receivable	45.07	38	7.6	-	-	-
Other Receivables	25.06	30.15	3.64	-	3.47	-
Total Trade Receivables	70.13	68.15	11.24	-	3.47	-
Inventory	33.16	32.75	0.37	-	-	-
Other Current Assets	17.48	13.5	8.54	3.29	1.92	1.57
Total Current Assets	675.04	528.08	603.06	580.88	489.79	448.4
Net Property, Plant & Equipment	1.29	1.52	2.02	1.5	1.06	1.26
Long-Term Investments	27.22	-	119.52	29.83	5.47	-
Other Long-Term Assets	0.1	0.1	0.22	0.68	0.92	-
Total Assets	703.65	529.71	724.82	612.88	497.24	449.66
Accounts Payable	4.87	16.58	11.63	9.96	4.35	5.67
Accrued Expenses	94.3	103.06	60.1	39.86	24.28	14.47
Current Portion of Leases	0.51	0.47	0.48	1.05	0.44	0.36
Other Current Liabilities	-	-	31.35	7.23	-	0.19
Total Current Liabilities	99.68	120.12	103.55	58.1	29.07	20.68
Long-Term Debt	244.09	-	-	-	-	19.9
Long-Term Leases	0.76	1.05	1.58	0.59	0.72	0.71
Other Long-Term Liabilities	344.03	343.91	331.57	-	-	-
Total Long-Term Liabilities	588.88	344.96	333.14	0.59	0.72	20.61
Total Liabilities	688.55	465.08	436.69	58.68	29.79	41.29
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-in Capital	1,614	1,571	1,509	1,456	1,161	952.02
Accumulated Other Comprehensive Income	-0.14	0.45	0.16	0.22	-0.81	0.05
Retained Earnings	-1,599	-1,507	-1,221	-902.4	-693.04	-543.7
Shareholders' Equity	15.1	64.63	288.12	554.2	467.45	408.37
Total Liabilities & Equity	703.65	529.71	724.82	612.88	497.24	449.66
Total Debt	245.36	1.52	2.06	1.64	1.16	20.97
Net Cash (Debt)	308.91	412.16	580.86	575.95	483.24	425.86
Net Cash Growth	-33.86%	-29.04%	0.85%	19.19%	13.47%	56.26%
Net Cash Per Share	3.52	4.76	6.78	8.19	7.95	7.94
Book Value	15.1	64.63	288.12	554.2	467.45	408.37
Book Value Per Share	0.17	0.75	3.37	7.88	7.69	7.62
Tangible Book Value	15.1	64.63	288.12	554.2	467.45	408.37
Tangible Book Value Per Share	0.17	0.75	3.37	7.88	7.69	7.62

SEC Filings: 10-K · 10-Q